Our group has demonstrated that human ovarian cancer cells and tumor-associated macrophage (TAM) produced chemokine CCL22, the ligand for CCR4 which functionally expressed on tumor TReg cells, mediating TReg cells trafficking to the tumor and ascites, and the blockade of CCL22 abrogated TReg cells migration [4]. This evidence concerns the gene CCR4 and neoplasm.